- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy high growth potential
South Korean Pharmaceuticals & Biotech Healthy high growth potential
Results
4
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
4 companies
Oscotec
Market Cap: ₩1.1t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩28,400.00
7D
-9.0%
1Y
-10.1%
ALTEOGEN
Market Cap: ₩15.0t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩279,500.00
7D
-8.8%
1Y
-38.4%
HansBiomed
Market Cap: ₩257.3b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩18,040.00
7D
-13.7%
1Y
122.7%
DreamCIS
Market Cap: ₩60.3b
Operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada.
A223250
₩2,450.00
7D
-18.7%
1Y
-25.5%